Date of Award

10-25-2022

Document Type

Dissertation

Degree Name

Molecular Biosciences, Ph.D.

First Advisor

Jianfeng Xu

Committee Members

Asela Wijeratne; Fabricio Medina-Bolivar; Maureen Dolan; Vibha Srivastava

Call Number

LD 251 .A566d 2022 K37

Abstract

Plant cell culture is emerging as a promising alternative bioproduction platform for valuable proteins due to its low cost of production, safety (free from animal pathogen contamination) and ease of scale-up. However, there are common challenges for commercialization, including low protein yields, difficulty in cryopreservation, and non-human glycosylation, etc. This research project addresses the overarching research hypothesis that strategically modifying the plant cell genome using CRISPR/Cas9 technology and rationally designing protein molecules by fusing with a functional module enhance the production of protein in plant cell culture and improve protein function. There are two specific aims addressed in this project: Aim1: Explore cellular engineering of plant cells to improve protein production; Aim 2: Rationally design and engineer protein molecules in plant cells for enhanced bioproduction and function. Specifically, Aim 1 investigated cellular engineering of plant cells to create cell wall deficient (CWD) cell lines. Bright Yellow-2 (BY-2) cell lines with substantially reduced cellulose content were created by either chemical treatment with a cellulose synthesis inhibitor or CRISPR/Cas9 genome editing technology. The viability, morphology, transcriptomics, and bioproductivity of the created CWD cells were characterized. CWD BY-2 cells generated by either chemical treatment or genome editing formed large clumps, and their cellulose content was drastically reduced by 80 % and 40 %, respectively. Aim 2 leveraged two unique post-translational modifications –“Hydroxyproline (Hyp)-O-glycosylation” and “Glycosylphosphati-dylinositol (GPI) anchor”– to strategically design and engineer proteins in plant cells to improve production and function. A Hyp-O-glycosylation module composed of 20 repeats of the “Ser-Pro” motif was engineered to human erythropoietin (EPO) to substantially increase the secreted protein yields in BY-2 cell culture up to 8.61 μg/mL. GPI-anchored proteins, including reporter protein, therapeutic protein and enzyme, was engineered into BY-2 cells and tobacco plants. GPI anchor was found to facilitate the intracellular trafficking and glycosylation (Hyp-O-linked and N-/O-linked glycosylation) of the anchored proteins. This study establishes proof-of-concept for top-down plant cell wall engineering to create CWD plant cell lines, and provides a new biomolecular engineering strategy to improve and expand plant-based production.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.